Suppr超能文献

结核分枝杆菌对抗抗原呈递的逃避与颠覆

Evasion and subversion of antigen presentation by Mycobacterium tuberculosis.

作者信息

Baena A, Porcelli S A

机构信息

Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

出版信息

Tissue Antigens. 2009 Sep;74(3):189-204. doi: 10.1111/j.1399-0039.2009.01301.x. Epub 2009 Jun 25.

Abstract

Mycobacterium tuberculosis is one of the most successful of human pathogens and has acquired the ability to establish latent or progressive infection and persist even in the presence of a fully functioning immune system. The ability of M. tuberculosis to avoid immune-mediated clearance is likely to reflect a highly evolved and coordinated program of immune evasion strategies, including some that interfere with antigen presentation to prevent or alter the quality of T-cell responses. Here, we review an extensive array of published studies supporting the view that antigen presentation pathways are targeted at many points by pathogenic mycobacteria. These studies show the multiple potential mechanisms by which M. tuberculosis may actively inhibit, subvert or otherwise modulate antigen presentation by major histocompatibility complex class I, class II and CD1 molecules. Unraveling the mechanisms by which M. tuberculosis evades or modulates antigen presentation is of critical importance for the development of more effective new vaccines based on live attenuated mycobacterial strains.

摘要

结核分枝杆菌是人类最具致病性的病原体之一,它已具备在免疫系统功能完全正常的情况下建立潜伏或进行性感染并持续存在的能力。结核分枝杆菌逃避免疫介导清除的能力很可能反映了一种高度进化且协调的免疫逃逸策略程序,其中包括一些干扰抗原呈递以预防或改变T细胞反应质量的策略。在此,我们综述了大量已发表的研究,这些研究支持了致病性分枝杆菌在多个环节靶向抗原呈递途径这一观点。这些研究揭示了结核分枝杆菌可能通过多种潜在机制主动抑制、破坏或调控主要组织相容性复合体I类、II类分子以及CD1分子的抗原呈递。阐明结核分枝杆菌逃避或调控抗原呈递的机制对于开发基于减毒活分枝杆菌菌株的更有效新型疫苗至关重要。

相似文献

1
Evasion and subversion of antigen presentation by Mycobacterium tuberculosis.
Tissue Antigens. 2009 Sep;74(3):189-204. doi: 10.1111/j.1399-0039.2009.01301.x. Epub 2009 Jun 25.
2
Evasion of Innate and Adaptive Immunity by Mycobacterium tuberculosis.
Microbiol Spectr. 2014 Oct;2(5). doi: 10.1128/microbiolspec.MGM2-0005-2013.
4
Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection.
Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11786-91. doi: 10.1073/pnas.93.21.11786.
5
Evasion of peptide, but not lipid antigen presentation, through pathogen-induced dendritic cell maturation.
Proc Natl Acad Sci U S A. 2008 Aug 12;105(32):11281-6. doi: 10.1073/pnas.0804681105. Epub 2008 Aug 6.
6
Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis.
Nat Med. 2003 Aug;9(8):1039-46. doi: 10.1038/nm906. Epub 2003 Jul 20.
7
Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors.
Nat Rev Microbiol. 2010 Apr;8(4):296-307. doi: 10.1038/nrmicro2321.
8
Mycobacterium tuberculosis PPE18 protein inhibits MHC class II antigen presentation and B cell response in mice.
Eur J Immunol. 2021 Mar;51(3):603-619. doi: 10.1002/eji.201848071. Epub 2020 Dec 1.
9
Mycobacterium tuberculosis: immune evasion, latency and reactivation.
Immunobiology. 2012 Mar;217(3):363-74. doi: 10.1016/j.imbio.2011.07.008. Epub 2011 Jul 18.

引用本文的文献

2
and host interactions in the manifestation of tuberculosis.
J Clin Tuberc Other Mycobact Dis. 2024 Jun 14;36:100458. doi: 10.1016/j.jctube.2024.100458. eCollection 2024 Aug.
4
The functional response of human monocyte-derived macrophages to serum amyloid A and infection.
Front Immunol. 2023 Sep 15;14:1238132. doi: 10.3389/fimmu.2023.1238132. eCollection 2023.
5
Advances of Long Non-Coding RNAs as Potential Biomarkers for Tuberculosis: New Hope for Diagnosis?
Pharmaceutics. 2023 Aug 7;15(8):2096. doi: 10.3390/pharmaceutics15082096.
7
Metformin Increases Cell Viability and Regulates Pro-Inflammatory Response to Mtb.
Infect Drug Resist. 2023 Jun 7;16:3629-3638. doi: 10.2147/IDR.S401403. eCollection 2023.
8
The paradox of immune checkpoint inhibition re-activating tuberculosis.
Eur Respir J. 2022 Nov 10;60(5). doi: 10.1183/13993003.02512-2021. Print 2022 Nov.
9
Gut microbiome-derived glycine lipids are diet-dependent modulators of hepatic injury and atherosclerosis.
J Lipid Res. 2022 Apr;63(4):100192. doi: 10.1016/j.jlr.2022.100192. Epub 2022 Mar 10.
10
The PE_PGRS Protein Family Acts as an Immunological Decoy to Subvert Host Immune Response.
Int J Mol Sci. 2022 Jan 4;23(1):525. doi: 10.3390/ijms23010525.

本文引用的文献

1
Antimicrobial mechanisms of phagocytes and bacterial evasion strategies.
Nat Rev Microbiol. 2009 May;7(5):355-66. doi: 10.1038/nrmicro2128.
2
TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis.
Cell Immunol. 2009;258(1):29-37. doi: 10.1016/j.cellimm.2009.03.008. Epub 2009 Apr 11.
3
Cell-mediated immune responses in tuberculosis.
Annu Rev Immunol. 2009;27:393-422. doi: 10.1146/annurev.immunol.021908.132703.
5
Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys.
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2301-6. doi: 10.1073/pnas.0712077106. Epub 2009 Feb 2.
6
Mycolic acids constitute a scaffold for mycobacterial lipid antigens stimulating CD1-restricted T cells.
Chem Biol. 2009 Jan 30;16(1):82-92. doi: 10.1016/j.chembiol.2008.11.008.
7
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
Am J Respir Crit Care Med. 2009 Apr 15;179(8):724-33. doi: 10.1164/rccm.200809-1486OC. Epub 2009 Jan 16.
9
Viral evasion and subversion of pattern-recognition receptor signalling.
Nat Rev Immunol. 2008 Dec;8(12):911-22. doi: 10.1038/nri2436.
10
Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death.
J Exp Med. 2008 Nov 24;205(12):2791-801. doi: 10.1084/jem.20080767. Epub 2008 Oct 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验